Cargando…
COVID-19 in Patients with Rheumatic Disease Using Immunomodulatory Drugs: Imaging Findings and Predictors of Hospitalization
INTRODUCTION: SARS-CoV-2 causes more severe symptoms in most chronic diseases, and rheumatic disease is no exception. This study aims to investigate whether there is an association between the use of immunomodulatory medications, including conventional disease-modifying agents (csDMARDs), glucocorti...
Autores principales: | Azizi, Hossein, Karimi, Hanie, Kazemi, Mahdi, Rezaei, Somaye Sadat, Parsaei, Amirhossein, Aghaali, Mohammad, Vafaeimanesh, Jamshid, Torabi, Pouya, Amini, Behnam, Masoumi, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716495/ https://www.ncbi.nlm.nih.gov/pubmed/36475037 http://dx.doi.org/10.1007/s40744-022-00508-y |
Ejemplares similares
-
Oral health-related quality of life in rheumatoid arthritis: a comparative analysis
por: Parsaei, Amirhossein, et al.
Publicado: (2022) -
Prevalence of coronavirus disease 2019 in rheumatic patients and evaluation of the effect of disease-modifying anti-rheumatic drugs
por: Moradi, Soroush, et al.
Publicado: (2020) -
Ventricular and atrial function assessment with transthoracic echocardiography in patients with rheumatic inflammatory disease
por: Norouzi, Somayyeh, et al.
Publicado: (2022) -
Sarcoidosis with multiple organ involvement and uncommon symptoms: A case report
por: Khalaji, Amirmohammad, et al.
Publicado: (2022) -
Esophageal Polyp Lesion in a Patient with Globus Pharyngeus Compliant
por: Boghratian, Amirhossein, et al.
Publicado: (2020)